Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;22(3):e2100116.
doi: 10.1002/pmic.202100116. Epub 2021 Nov 2.

Passages in culture and stimulation conditions influence protein expression of primary fibroblasts

Affiliations

Passages in culture and stimulation conditions influence protein expression of primary fibroblasts

Solange Vivier et al. Proteomics. 2022 Feb.

Abstract

Fibroblasts (Fb) are key effector cells in systemic sclerosis (SSc). Fb stimulation with transforming growth factor beta 1 (TGF-β1) is considered as a positive control in studies assessing fibrogenesis. The lack of standardization of TGF-β1 stimulation might be responsible for discrepancies in experiments performed in different conditions. Using quantitative proteomics analysis, we evaluated the impact of changes in experimental conditions on proteomic profiles of primary Fb. Principal component analysis (PCA) identified several groups of differentially expressed proteins influenced by cell passage, culture medium, and both concentration and duration of exposure to TGF-β1 stimulation. Bioinformatics analysis revealed that late passages expressed proteins involved in senescence. TGF-β1 concentration and time of stimulation were correlated with the expression of proteins involved in the fibrogenesis and inflammatory processes. These data underline the need for standardization of culture conditions to allow inter-data comparisons in future in vitro studies, especially when using "omics" approaches.

Keywords: TGF-β1; fibrosis; primary fibroblasts; proteomics; systemic sclerosis.

PubMed Disclaimer

References

REFERENCES

    1. Rockey, D. C., Bell, P. D., & Hill, J. A. (2015). Fibrosis - a common pathway to organ injury and failure. New England Journal of Medicine, 372(12), 1138-1149.
    1. Denton, C. P., & Khanna, D. (2017). Systemic sclerosis. The Lancet, 390, 1685-1699.
    1. Garret, S. M., Frost, D. B., & Feghali-Bostwick, C. (2017). The mighty fibroblast and its utility in scleroderma research. Journal of Scleroderma Related Disorders, 2(2), 69-134.
    1. Lodyga, M., & Hinz, B. (2020). TGF-β1 - a truly transforming growth factor in fibrosis and immunity. Seminars in Cell & Developmental Biology, 101, 123-139.
    1. Speca, S., Giusti, I., Rieder, F., & Latella, G. (2012). Cellular and molecular mechanisms of intestinal fibrosis.World Journal of Gastroenterology, 18(28), 3635-3661.

Publication types

MeSH terms

Substances